1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    








































































































    Recombinant Tissue Plasminogen Activator Increases Blood-Brain Barrier Disruption in Acute Ischemic Stroke: An MR Imaging Permeability Study | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleBrain

  
      
Open Access

  
      
Recombinant Tissue Plasminogen Activator Increases Blood-Brain Barrier Disruption in Acute Ischemic Stroke: An MR Imaging Permeability Study
  
    	
A. Kassner, T.P.L. Roberts, B. Moran, F.L. Silver and D.J. Mikulis

  
    	
American Journal of Neuroradiology November 2009,  30 (10) 1864-1869; DOI: https://doi.org/10.3174/ajnr.A1774 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵


    1. del Zoppo  G, 
    2. von Kummer  R, 
    3. Hamann  GF
    . Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry 1998;65:1–9
    FREE Full Text
  2. 2.↵


    1. Smith  W, 
    2. Sung  G, 
    3. Starkman  S, 
    4. et al
    . Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432–38
    Abstract/FREE Full Text
  3. 3.↵


    1. Lyden  P, 
    2. Zivin  JA
    . Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence. Cerebrovasc Brain Met Rev 1993;5:1–16
  4. 4.↵


    Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke: The NINDS tPA Stroke Study Group. Stroke 1997;28:2109–18
    Abstract/FREE Full Text
  5. 5.↵


    1. Larrue  V, 
    2. von Kummer  R, 
    3. del Zoppo  G, 
    4. et al
    . Hemorrhagic transformation in acute ischemic stroke: potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 1997;28:957–60
    Abstract/FREE Full Text
  6. 6.↵


    1. Toni  D, 
    2. Fiorelli  M, 
    3. Bastianello  S, 
    4. et al
    . Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology 1996;46:41–45
    Abstract/FREE Full Text
  7. 7.↵


    1. Hacke  W, 
    2. Kaste  M, 
    3. Fieschi  C, 
    4. et al
    . Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017–25
    CrossRefPubMedWeb of Science
  8. 8.↵


    1. Hacke  W, 
    2. Kaste  M, 
    3. Fieschi  C, 
    4. et al
    . Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998;352:1245–51
    CrossRefPubMedWeb of Science
  9. 9.↵


    1. Jaillard  A, 
    2. Cornu  C, 
    3. Durieux  A, 
    4. et al
    . Hemorrhagic transformation in acute ischemic stroke: The MAST-E study. Stroke 1999;30:1326–32
    Abstract/FREE Full Text
  10. 10.↵


    Thrombolytic therapy with streptokinase in acute ischemic stroke: The Multicenter Acute Stroke Trial Europe Study Group. N Engl J Med 1996;335:145–50
    CrossRefPubMedWeb of Science
  11. 11.↵


    1. Hacke  W, 
    2. Kaste  M, 
    3. Bluhmki  E, 
    4. et al
    . Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317–29
    CrossRefPubMedWeb of Science
  12. 12.↵


    1. Baron  J, 
    2. von Kummer  R, 
    3. del Zoppo  GJ
    . Treatment of acute ischemic stroke: challenging the concept of a rigid and universal time window. Stroke 1999;30:180–82
    Abstract/FREE Full Text
  13. 13.↵


    1. Furlan  A, 
    2. Higashida  R, 
    3. Wechsler  L, 
    4. et al
    . Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study—A randomized clinical trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11
    CrossRefPubMedWeb of Science
  14. 14.↵


    1. Hacke  W, 
    2. Albers  G, 
    3. Al-Rawi  Y, 
    4. et al
    . The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute thrombolysis trial with intravenous desmoteplase. Stroke 2006;36:66–73
    CrossRef
  15. 15.↵


    1. Rowley  H
    . Successful patient selection with DWPW-MRI for IV treatment with desmoteplase at 3–9 hours: DIAS and DEDAS trial results. In: Proceedings of the American Society of Neuroradiology, Toronto, Ontario, Canada, May 21–27, 2005
  16. 16.↵


    1. Kassner  A, 
    2. Roberts  T, 
    3. Taylor  K, 
    4. et al
    . Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging. AJNR Am J Neuroradiol 2005;26:2213–17
    Abstract/FREE Full Text
  17. 17.↵


    1. Periaswamy  S
    . General-Purpose Medical Image Registration [PhD dissertation]. Hanover, NH: Dartmouth College; 2003
  18. 18.↵


    1. Roberts  H, 
    2. Roberts  TPL, 
    3. Brasch  RC, 
    4. et al
    . Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000;21:891–99
    Abstract/FREE Full Text
  19. 19.↵


    1. Ewing  JR, 
    2. Knight  RA, 
    3. Nagaraja  TN, 
    4. et al
    . Patlak plots of Gd-DTPA MRI data yield blood-brain transfer constants concordant with those of 14C-sucrose in areas of blood-brain opening. Magn Reson Med 2003;50:283–92
    CrossRefPubMedWeb of Science
  20. 20.↵


    1. Stejskal  E
    . Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys 1965;42:288–92
    CrossRefWeb of Science
  21. 21.↵


    R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2007
  22. 22.↵


    1. Cao  Y, 
    2. Brown  SL, 
    3. Knight  RA, 
    4. et al
    . Effect of intravascular-to-extravascular water exchange on the determination of blood-to-tissue transfer constant by magnetic resonance imaging. Magn Reson Med 2005;53:282–93
    CrossRefPubMed
  23. 23.↵


    1. Lin  K, 
    2. Kazmi  KS, 
    3. Law  M, 
    4. et al
    . Measuring elevated microvascular permeability and predicting hemorrhagic transformation in acute ischemic stroke using first-pass dynamic perfusion CT imaging. AJNR Am J Neuroradiol 2007;28:1292–98
    Abstract/FREE Full Text
  24. 24.↵


    1. Bisdas  S, 
    2. Hartel  M, 
    3. Cheong  LH, 
    4. et al
    . Prediction of subsequent hemorrhage in acute ischemic stroke using permeability CT imaging and a distributed parameter tracer kinetic model. J Neuroradiol 2007;34:101–08
    PubMed
  25. 25.↵


    1. Dankbaar  JW, 
    2. Hom  J, 
    3. Schneider  T, 
    4. et al
    . Dynamic perfusion CT assessment of the blood-brain barrier permeability: first pass versus delayed acquisition. AJNR Am J Neuroradiol 2008;29:1671–76
    Abstract/FREE Full Text
  26. 26.↵


    1. Rosell  A, 
    2. Ortega-Aznar  A, 
    3. Alvarez-Sabin  J, 
    4. et al
    . Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 2006;37:1399–406
    Abstract/FREE Full Text
  27. 27.↵


    1. Castellanos  M, 
    2. Leira  R, 
    3. Serena  J, 
    4. et al
    . Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 2003;34:40–46
    Abstract/FREE Full Text
  28. 28.↵


    1. Montaner  J, 
    2. Molina  CA, 
    3. Monasterio  J, 
    4. et al
    . Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 2003;107:598–603
    Abstract/FREE Full Text
  29. 29.↵


    1. Kastrup  A, 
    2. Gröschel  K, 
    3. Ringer  TM, 
    4. et al
    . Early disruption of the blood–brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke. Stroke 2008;39:2385–87
    Abstract/FREE Full Text
  30. 30.↵


    1. Nyormoi  O, 
    2. Mills  L, 
    3. Bar-Eli  M
    . An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells. Cell Death Differ 2003;10:558–69
    CrossRefPubMedWeb of Science
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Recombinant Tissue Plasminogen Activator Increases Blood-Brain Barrier Disruption in Acute Ischemic Stroke: An MR Imaging Permeability Study
  
    	
A. Kassner, T.P.L. Roberts, B. Moran, F.L. Silver, D.J. Mikulis

  
    	
 American Journal of Neuroradiology Nov 2009, 30 (10) 1864-1869; DOI: 10.3174/ajnr.A1774 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    

  

    
 Related Articles
  • No related articles found.
 Cited By...
 More in this TOC Section
 Similar Articles

  



  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement